The specificity of the signature for CRC is significantly mediated by TIMP1, PON1, and LRG1—the three proteins previously associated with CRC more directly and based on our observation that the abundance of PON1 and LRG1 in the circulation correlated with the tumor size in these patients, pointing toward tumor-specific markers. This evidence concerns the gene PON1 and colorectal carcinoma.